|
CEP57 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.162400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.682600E-01 |
| Normal-vs-Stage2 |
7.079200E-01 |
| Normal-vs-Stage3 |
2.202200E-01 |
| Normal-vs-Stage4 |
9.754200E-01 |
| Stage1-vs-Stage2 |
8.377200E-01 |
| Stage1-vs-Stage3 |
5.351800E-01 |
| Stage1-vs-Stage4 |
6.760800E-01 |
| Stage2-vs-Stage3 |
5.636600E-01 |
| Stage2-vs-Stage4 |
8.383800E-01 |
| Stage3-vs-Stage4 |
5.005600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.876200E-01 |
| Normal-vs-AfricanAmerican |
5.153600E-01 |
| Normal-vs-Asian |
5.385200E-01 |
| Caucasian-vs-AfricanAmerican |
8.884200E-01 |
| Caucasian-vs-Asian |
7.315200E-01 |
| AfricanAmerican-vs-Asian |
7.035800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.145630E-01 |
| Normal-vs-Female |
6.577000E-01 |
| Male-vs-Female |
1.082970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.220200E-01 |
| Normal-vs-Extreme_Weight |
3.658500E-02 |
| Normal-vs-Obese |
6.439800E-01 |
| Normal-vs-Extreme_Obese |
5.062100E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.052200E-01 |
| Normal_Weight-vs-Obese |
2.329200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.609000E-01 |
| Extreme_Weight-vs-Obese |
3.147500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.791600E-01 |
| Obese-vs-Extreme_Obese |
1.780770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.628800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.555200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.033880E-02 |
| Normal-vs-Age(81-100Yrs) |
6.242000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.280400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.324300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.855900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.078080E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.792000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.699600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.135800E-01 |
| Normal-VS-Type2 PRCC |
1.260350E-03 |
| Normal-VS-KIRP CIMP |
2.115400E-01 |
| Normal-VS-Unclassified PRCC |
9.267800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.444390E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.790640E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.113000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.954100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.703600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.260570E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.811740E-02 |
| Normal-vs-N1 |
6.365600E-01 |
| Normal-vs-N2 |
1.252330E-02 |
| N0-vs-N1 |
1.256360E-01 |
| N0-vs-N2 |
4.376200E-01 |
| N1-vs-N2 |
2.059600E-02 |
|
|
